Common heart drug may hold key to fighting silent liver epidemic
NCT ID NCT07238985
Summary
This study is testing whether a drug called cilostazol, already used for other conditions, can help treat nonalcoholic fatty liver disease (NAFLD). It will involve 50 adult patients with NAFLD to see if the drug safely reduces the amount of fat and scarring in their livers. The main goal is to see if this existing medication can be repurposed to control this common liver condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FATTY LIVER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mostafa Bahaa
RECRUITINGDamietta, New Damietta, 34518, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.